Correction to: Nature Communications https://doi.org/10.1038/s41467-019-12163-z, published online 8 October 2019.
This Article contained errors in Figs. 4i and 5a, for which the authors apologise. The lanes labelled ARNT (lower row) in Fig. 4i and HIF1alpha in Fig. 5a were not from the membranes used to probe for the other proteins shown in each panel. These have now been replaced with the correct rows from the same membranes. These errors were reproduced in the source data file that contains the uncropped membranes. The errors did not affect the conclusions of the manuscript. They have now been corrected both the PDF and HTML versions of the Article, and the Source Data file has been amended to include the correct images of the respective uncropped membranes.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Liang, C., Li, J., Lu, C. et al. Author Correction: HIF1α inhibition facilitates Leflunomide-AHR-CRP signaling to attenuate bone erosion in CRP-aberrant rheumatoid arthritis. Nat Commun 11, 3098 (2020). https://doi.org/10.1038/s41467-020-16901-6
Published:
DOI: https://doi.org/10.1038/s41467-020-16901-6
This article is cited by
-
Prodrug-based nanomedicines for rheumatoid arthritis
Discover Nano (2024)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.
